drugset / Trial / NCT02912169

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease

NCT02912169 ↗

Phase 1/2 Withdrawn Ageless Regenerative Institute
NaSingle-groupOpen-labelTreatment

Summary

The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with Alzheimer's Disease and clinical outcomes?

Timeline

Start
2015-11-01
Primary completion
2017-11-15
Completion
2017-11-15

Outcome

Outcome not reported

Stopped: “company dissolved”

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-SVF Cell therapy — Intravenous

Indications